{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:19:06Z","timestamp":1784330346894,"version":"3.55.0"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s286953","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T09:00:10Z","timestamp":1627290010000},"page":"755-763","source":"Crossref","is-referenced-by-count":16,"title":["Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Caitlin M","family":"Brumfiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera H","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1290-1415","authenticated-orcid":true,"given":"Katheryn A","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Cardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","volume":"172","author":"Tan","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/jid.2010.375","volume":"131","author":"Misery","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/ced.13919","volume":"44","author":"Singam","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jid.2010.264","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40168-018-0558-5","volume":"6","author":"O\u2019Neill","year":"2018","journal-title":"Microbiome"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jaad.2012.02.018","volume":"67","author":"Di Landro","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/bjd.17109","volume":"179","author":"Balak","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"Kolli","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.bmcl.2018.04.036","volume":"28","author":"Thoreau","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"ref14","unstructured":"Galderma. Aklief (trifarotene). US Food and Drug Administration. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211527s000lbl.pdf. Accessed April 17, 2021."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/bjd.16719","volume":"179","author":"Aubert","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref16","first-page":"s51","volume":"17","author":"Chien","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/ciia.2006.1.4.327","volume":"1","author":"Mukherjee","year":"2006","journal-title":"Clin Interv Aging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1566","author":"Wagner","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(83)90538-X","volume":"2","author":"Rosa","year":"1983","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"Tan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/jdv.15794","volume":"34","author":"Blume-Peytavi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","unstructured":"Clinicaltrials.gov. Subject reported outcomes with use of trifarotene 50 \u03bcg\/g cream in the treatment of moderate facial and truncal acne vulgaris. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03915860?term=trifarotene&cond=Acne+Vulgaris&draw=2&rank=1. Accessed April 28, 2021."},{"key":"ref23","unstructured":"Clinicaltrials.gov. Dose Range Study of CD5789 in acne vulgaris. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01616654?term=trifarotene&cond=Acne+Vulgaris&draw=2&rank=7. Accessed April 28, 2021."},{"key":"ref24","unstructured":"Clinicaltrials.gov. A study to compare efficacy and safety of trifarotene cream when used with an oral antibiotic for the treatment of severe acne vulgaris (AV) (DUAL). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04451330?term=trifarotene&cond=Acne+Vulgaris&draw=2&rank=5. Accessed April 28, 2021."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s13555-020-00417-4","volume":"10","author":"Johnson","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/pharmaceutics11100490","volume":"11","author":"Latter","year":"2019","journal-title":"Pharmaceutics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1060028020934892","volume":"55","author":"Bell","year":"2021","journal-title":"Ann Pharmacother"},{"key":"ref29","unstructured":"GoodRx. Aklief. Available from: https:\/\/www.goodrx.com\/aklief?dosage=45g-of-0.005%25&form=cream-pump&label_override=Aklief&quantity=1&sort_type=popularity. Accessed April 17, 2021."},{"key":"ref30","unstructured":"GoodRx. Tretinoin. Available from: https:\/\/www.goodrx.com\/tretinoin?dosage=45g-of-0.025%25&form=tube-of-cream&label_override=tretinoin&quantity=1&sort_type=popularity. Accessed April 17, 2021."},{"key":"ref31","unstructured":"GoodRx. Adapalene. Available from: https:\/\/www.goodrx.com\/differin?dosage=45g-of-0.1%25&form=tube-of-gel&label_override=adapalene&quantity=1&sort_type=popularity. Accessed April 17, 2021."},{"key":"ref32","unstructured":"Galderma. Aklief savings. Available from: https:\/\/aklief.com\/savings. Accessed April 17, 2021."}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72057","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72057","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T09:00:34Z","timestamp":1627290034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/assessing-the-safety-and-efficacy-of-trifarotene-in-the-treatment-of-a-peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s286953","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}